Synthesis of a highly active new anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine. 2003

Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.

Compounds having methyl, vinyl, and ethynyl groups at the 4'-position of stavudine (d4T: 2',3'-didehydro-3'-deoxythymidine) were synthesized. The compounds were assayed for their ability to inhibit the replication of HIV in cell culture. The 4'-ethynyl analogue (15) was found to be more potent and less toxic than the parent compound stavudine.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D018119 Stavudine A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. 2',3'-Didehydro-3'-deoxythymidine,D4T,2',3'-Didehydro-2',3'-dideoxythmidine,BMY-27857,Stavudine, Monosodium Salt,Zerit,2',3' Didehydro 3' deoxythymidine,BMY 27857,BMY27857
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
June 2006, The Journal of organic chemistry,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
August 2005, Antimicrobial agents and chemotherapy,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
November 2007, Antimicrobial agents and chemotherapy,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
August 2009, Antimicrobial agents and chemotherapy,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
February 1991, Biochemical and biophysical research communications,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
August 2023, ACS bio & med chem Au,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
June 1993, Clinical and experimental immunology,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
January 2002, Organic letters,
Kazuhiro Haraguchi, and Shingo Takeda, and Hiromichi Tanaka, and Takao Nitanda, and Masanori Baba, and G E Dutschman, and Yung-Chi Cheng
February 2006, Arzneimittel-Forschung,
Copied contents to your clipboard!